2. Classification and Diagnosis of Diabetes

1. Type 1 diabetes (due to autoimmune b-cell destruction, usually leading to absolute insulin deficiency) 2. Type 2 diabetes (due to a progressive loss ofb-cell insulin secretion frequently on the background of insulin resistance) 3. Gestational diabetes mellitus (GDM) (diabetes diagnosed in the second or third trimester of pregnancy that was not clearly overt diabetes prior to gestation) 4. Specific types of diabetes due to other causes, e.g., monogenic diabetes syndromes (such as neonatal diabetes and maturity-onset diabetes of the young [MODY]), diseases of the exocrine pancreas (such as cystic fibrosis), and drugor chemical-induced diabetes (such as with glucocorticoid use, in the treatment of HIV/AIDS, or after organ transplantation)

[1]  T. Hannon,et al.  Using hemoglobin A1c for prediabetes and diabetes diagnosis in adolescents: can adult recommendations be upheld for pediatric use? , 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[2]  Viola Vaccarino,et al.  Glucose-Independent, Black–White Differences in Hemoglobin A1c Levels , 2010, Annals of Internal Medicine.

[3]  Cuilin Zhang,et al.  International Association of Diabetes and Pregnancy Study Group criteria is suitable for gestational diabetes mellitus diagnosis: further evidence from China , 2014, Chinese medical journal.

[4]  A. Moran,et al.  New insights into cystic fibrosis-related diabetes in children. , 2013, The lancet. Diabetes & endocrinology.

[5]  Caroline A Crowther,et al.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. , 2005, The New England journal of medicine.

[6]  E. Ford,et al.  Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the U.S. Population in 1988–2006 , 2010, Diabetes Care.

[7]  Dwight J Rouse,et al.  A multicenter, randomized trial of treatment for mild gestational diabetes. , 2009, The New England journal of medicine.

[8]  J. Coresh,et al.  No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes , 2013, Diabetes Care.

[9]  W. Fujimoto,et al.  BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening , 2014, Diabetes Care.

[10]  Jasmin Divers,et al.  Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. , 2014, JAMA.

[11]  H. Bastian,et al.  Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[12]  P. Zeitler,et al.  Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children , 2012, International Journal of Pediatric Endocrinology.

[13]  V. Basevi.  Standards of Medical Care in Diabetes—2011 , 2011, Diabetes Care.

[14]  Isabelle Runkle,et al.  Introduction of IADPSG Criteria for the Screening and Diagnosis of Gestational Diabetes Mellitus Results in Improved Pregnancy Outcomes at a Lower Cost in a Large Cohort of Pregnant Women: The St. Carlos Gestational Diabetes Study , 2014, Diabetes Care.

[15]  Lorie M. Harper,et al.  Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes , 2016, Obstetrics and gynecology.

[16]  Anil Bhansali,et al.  Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. , 2010, The Journal of clinical endocrinology and metabolism.

[17]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[18]  E. Bonifacio,et al.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. , 2013, JAMA.

[19]  刘欣,et al.  Clinical care guidelines for cystic fibrosis-related diabetes:a position statement of the Americal Diabetess Association and a clinical practice guideline of the Cystic Fibrosis Foundation ,endorsed by the pedistric Endocrine Society , 2011 .

[20]  J. Shaw,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[21]  J. Bernasko.  Gestational Diabetes Screening: The International Association of the Diabetes and Pregnancy Study Groups Compared With Carpenter-Coustan Screening. , 2016, Obstetrics and gynecology.

[22]  B. Vandermeer,et al.  This online-first article will have minor typographical differences from the final, printed version. Annals of Internal Medicine Screening Tests for Gestational Diabetes: A Systematic Review for the U.S. Preventive Services Task Force , 2013 .

[23]  D. Williamson,et al.  Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005-2006. , 2011, American journal of preventive medicine.

[24]  Å. Lernmark,et al.  Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association , 2015, Diabetes Care.

[25]  F. Kaufman,et al.  Diabetes Screening With Hemoglobin A1c Versus Fasting Plasma Glucose in a Multiethnic Middle-School Cohort , 2013, Diabetes Care.

[26]  S. Caprio,et al.  Utility of Hemoglobin A1c for Diagnosing Prediabetes and Diabetes in Obese Children and Adolescents , 2011, Diabetes Care.

[27]  E. Paschos.  Dental findings and identification of undiagnosed hyperglycemia , 2014, Journal of Orofacial Orthopedics / Fortschritte der Kieferorthopädie.

[28]  N. Emanuele,et al.  The association between glycemic control and clinical outcomes after kidney transplantation. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[29]  Peter C. Austin,et al.  Deriving Ethnic-Specific BMI Cutoff Points for Assessing Diabetes Risk , 2011, Diabetes Care.

[30]  Bethany J Figg,et al.  National Institute of Child Health and Human Development , 2013 .

[31]  Lyn Yasumura,et al.  Gestational Diabetes Screening: The International Association of the Diabetes and Pregnancy Study Groups Compared With Carpenter-Coustan Screening , 2016, Obstetrics and gynecology.

[32]  D. Coustan,et al.  Criteria for screening tests for gestational diabetes. , 1982, American journal of obstetrics and gynecology.

[33]  E. Bonifacio,et al.  Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis , 2016, Diabetes.

[34]  A. Sharif,et al.  The Use of Oral Glucose Tolerance Tests to Risk Stratify for New-Onset Diabetes After Transplantation: An Underdiagnosed Phenomenon , 2006, Transplantation.

[35]  A. Hartmann,et al.  Fasting Plasma Glucose and Glycosylated Hemoglobin in the Screening for Diabetes Mellitus After Renal Transplantation , 2009, Transplantation.

[36]  Bengt Persson,et al.  International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy , 2010, Diabetes Care.

[37]  E. Bonifacio,et al.  Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY) , 2015, Diabetes Care.

[38]  W. Herman,et al.  Community-based screening for diabetes in Michigan. , 2003, Diabetes care.

[39]  J. Stockman.  Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes , 2007 .

[40]  I. Lamster,et al.  Identification of Unrecognized Diabetes and Pre-diabetes in a Dental Setting , 2011, Journal of dental research.

[41]  A. Hattersley,et al.  The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study , 2015, The Lancet.

[42]  A. Hattersley,et al.  The diagnosis and management of monogenic diabetes in children and adolescents , 2009, Pediatric diabetes.

[43]  P. Catalano,et al.  Perinatal Outcomes Associated With the Diagnosis of Gestational Diabetes Made by The International Association of the Diabetes and Pregnancy Study Groups Criteria , 2014, Obstetrics and gynecology.

[44]  Stasia Hadjiyannakis,et al.  Type 2 Diabetes in Children and Adolescents. , 2018, Canadian journal of diabetes.

[45]  R. Bergenstal,et al.  Response to Comment on: Selvin et al. No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes. Diabetes Care 2013;36:2995–3001 , 2013, Diabetes Care.

[46]  J. Widimský,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.

[47]  V. Gebski,et al.  Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus , 2016, BMJ Open.

[48]  W. Herman,et al.  The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age. , 2005, Diabetes care.

[49]  S. Saydah,et al.  Trends in the Prevalence of Ketoacidosis at Diabetes Diagnosis: The SEARCH for Diabetes in Youth Study , 2014, Pediatrics.

[50]  S. Brink,et al.  International Society for Pediatric and Adolescent Diabetes (ISPAD) , 2007 .

[51]  Aaron N. Winn,et al.  Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications , 2013, Diabetes Care.

[52]  Helen X. Gao,et al.  Prevalence of and trends in diabetes among adults in the United States, 1988-2012. , 2016, Journal of diabetes.

[53]  Morton B. Brown,et al.  Screening for prediabetes and type 2 diabetes in dental offices , 2015, Journal of public health dentistry.

[54]  L. Philipson,et al.  Neonatal Diabetes: An Expanding List of Genes Allows for Improved Diagnosis and Treatment , 2011, Current diabetes reports.

[55]  P. Raskin,et al.  Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. , 2004, Archives of internal medicine.

[56]  Practice Bulletin No. 137: Gestational diabetes mellitus. , 2013, Obstetrics and gynecology.

[57]  Joyce M Lee,et al.  Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia. , 2013, JAMA pediatrics.

[58]  A. Thanopoulou,et al.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.

[59]  L. Philipson,et al.  A Clinical Guide to Monogenic Diabetes , 2016 .

[60]  D. Margolis,et al.  Issues With the Diagnosis and Classification of Hyperglycemia in Early Pregnancy , 2015, Diabetes Care.

[61]  B. Poindexter,et al.  NIH consensus development conference: diagnosing gestational diabetes mellitus. , 2013, NIH consensus and state-of-the-science statements.

[62]  D. Williamson,et al.  A1C Level and Future Risk of Diabetes: A Systematic Review , 2010, Diabetes Care.

[63]  N. Melamed,et al.  The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. , 2015, American journal of obstetrics and gynecology.

[64]  P. Heneberg,et al.  Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[65]  Justin Feigelman,et al.  Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis , 2010, The Lancet.

[66]  A. Stolfi,et al.  Insulin and oral agents for managing cystic fibrosis-related diabetes. , 2005, The Cochrane database of systematic reviews.

[67]  C. Lewis,et al.  Do glycemic marker levels vary by race? Differing results from a cross-sectional analysis of individuals with and without diagnosed diabetes , 2016, BMJ Open Diabetes Research and Care.

[68]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[69]  V. Tillmann,et al.  International Society for Pediatric and Adolescent Diabetes , 1998, Hormone Research in Paediatrics.

[70]  Kamlesh Khunti,et al.  Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial , 2011, The Lancet.

[71]  Kamlesh Khunti,et al.  Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe) , 2015, Diabetes Care.

[72]  S. Kahn,et al.  Optimum BMI Cut Points to Screen Asian Americans for Type 2 Diabetes , 2015, Diabetes Care.

[73]  C. Pettker,et al.  Screening for Gestational Diabetes Mellitus: Are the Criteria Proposed by the International Association of the Diabetes and Pregnancy Study Groups Cost-Effective? , 2012, Diabetes Care.

[74]  Jeffrey P. Krischer,et al.  Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 , 2009, Diabetes Care.